These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 13979418)
1. [Clinical experiences with the muscle relaxant antirheumatic preparations Quilil and Quilacortin]. SUTTER M Schweiz Med Wochenschr; 1963 May; 93():680-3. PubMed ID: 13979418 [No Abstract] [Full Text] [Related]
2. [Orthopedic and clinical experiences with Quilil and Quilicortin in the treatment of degenerative spinal diseases and coxarthroses]. RUHLAND D Med Klin; 1962 Sep; 57():1605-16. PubMed ID: 13975470 [No Abstract] [Full Text] [Related]
3. [Experiences with the muscle-relaxing agent Quilil in the treatment of diseases of the locomotor apparatus]. GRAF HP Praxis; 1962 Aug; 51():793-4. PubMed ID: 13900979 [No Abstract] [Full Text] [Related]
4. [EXPERIENCES WITH OFEROL IN RHEUMATIC MUSCULAR AND TENDON PAINS]. ENDLER B Ther Umsch; 1964 Feb; 21():60-3. PubMed ID: 14137301 [No Abstract] [Full Text] [Related]
5. [On the treatment of osteochondrosis in daily practice]. FRIEDRICH R Hippokrates; 1962 Nov; 33():951-2. PubMed ID: 13959834 [No Abstract] [Full Text] [Related]
6. A CONTROLLED COMPARISON OF THREE MUSCLE RELAXANT AGENTS. STERN FH Clin Med (Northfield); 1964 Feb; 71():367-72. PubMed ID: 15446116 [No Abstract] [Full Text] [Related]
7. [Treatment of painful neuromuscular conditions by a central muscle relaxant and its combinations]. BLANK KH Med Welt; 1963 Mar; 11():594-5. PubMed ID: 13971506 [No Abstract] [Full Text] [Related]
8. [On the clinical basis of infiltration and operative treatment of patients with scalenus anticus syndrome]. Popelianskiĭ IaIu; Kipervas IP Vopr Neirokhir; 1968; 32(2):22-5. PubMed ID: 5659254 [No Abstract] [Full Text] [Related]
10. Musculoskeletal disorders amenable to treatment with intravenous methocarbamol. FLINCHUM D Clin Med (Northfield); 1961 Nov; 8():2121-33. PubMed ID: 15445748 [No Abstract] [Full Text] [Related]
11. [On several clinical and morphologic comparisons in a syndrome of the anterior scalenus muscle]. Kipervas IP; Zaĭtseva RL Arkh Patol; 1967; 29(7):63-5. PubMed ID: 5629016 [No Abstract] [Full Text] [Related]
12. Clinical results with methocarbamol, a new interneuronal blocking agent. PARK HW J Am Med Assoc; 1958 May; 167(2):168-72. PubMed ID: 13538685 [No Abstract] [Full Text] [Related]
13. Plasma levels of mephenesin, mephenesin carbamate, guaiacol glyceryl ether, and methocarbamol (AHR-85) after oral and intravenous administration in the dog. MORGAN AM; TRUITT EH; LITTLE JM J Am Pharm Assoc Am Pharm Assoc; 1957 Jun; 46(6):374-7. PubMed ID: 13491400 [No Abstract] [Full Text] [Related]
14. Methocarbamol; new agent in treatment of neurological and neuromuscular diseases. O'DOHERTY DS; SHIELDS CD J Am Med Assoc; 1958 May; 167(2):160-3. PubMed ID: 13538683 [No Abstract] [Full Text] [Related]
15. Muscle relaxant activity of methocarbamol enantiomers in mice. Souri E; Sharifzadeh M; Farsam H; Gharavi N J Pharm Pharmacol; 1999 Jul; 51(7):853-5. PubMed ID: 10467962 [TBL] [Abstract][Full Text] [Related]
16. [The use of a muscle relaxant (methocarbamol) in threatened premature labor]. MANGIAMELI S Riv Ostet Ginecol Prat; 1960 Feb; 42():112-4. PubMed ID: 14420633 [No Abstract] [Full Text] [Related]
17. [Clinical experiences with a new phenacetin-free combination analgesic (Solco 7)]. GAENSSLEN H Praxis; 1962 Feb; 51():125-7. PubMed ID: 13896145 [No Abstract] [Full Text] [Related]
18. [Therapeutic trials in the treatment of rheumatic and neuralgic diseases using a new type myotonolytic antirheumatic drug]. FOCKE W Hippokrates; 1961 Aug; 32():662-3. PubMed ID: 13700430 [No Abstract] [Full Text] [Related]
19. [THERAPY OF VERTEBRAGENIC PAIN SYNDROMES WITH PARAFLEX]. PETER M Ther Umsch; 1964 Feb; 21():58-60. PubMed ID: 14137300 [No Abstract] [Full Text] [Related]